Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2006

01-11-2006 | Concise Article

Prevalence and genetic relatedness of community-acquired methicillin-resistant Staphylococcus aureus in Israel

Authors: G. Regev-Yochay, Y. Carmeli, M. Raz, E. Pinco, J. Etienne, A. Leavitt, E. Rubinstein, S. Navon-Venezia

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2006

Login to get access

Abstract

The aims of the study presented here were to determine the prevalence of Staphylococcus aureus carriage and, specifically, community-acquired methicillin-resistant S. aureus (CA-MRSA) carriage in children and their parents in Israel and to determine the genetic relatedness of these isolates. S. aureus was isolated from 580 of 3,373 (17.2%) individuals screened. The predominant type identified by pulsed-field gel electrophoresis was strain ST45-MSSA (25%). Five MRSA isolates were detected, and two of these were classified as CA-MRSA, based on the following criteria: no previous contact with a healthcare facility, absence of a multidrug-resistant (MDR) phenotype, and presence of SCCmec type IV. Isolates were negative for pvl and were classified as ST-45-MRSA. Although CA-MRSA is still rare in Israel, the genetic relatedness of the strains found in this study to a successful MSSA clone warrants close follow up.
Literature
1.
go back to reference Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylocccus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59PubMedCrossRef Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylocccus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59PubMedCrossRef
2.
go back to reference Netola N, Francis JS, Nuermberger EL, Bishai WR (2005) Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5:275–286CrossRef Netola N, Francis JS, Nuermberger EL, Bishai WR (2005) Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5:275–286CrossRef
3.
go back to reference Vandenesch F, Naimi T, Enright MC et al (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9:978–984PubMed Vandenesch F, Naimi T, Enright MC et al (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9:978–984PubMed
4.
go back to reference Regev-Yochay G, Rubinstein E, Barzilai A, Carmeli Y, Kuint J, Etienne J, Blech M, Smollen G, Maayan-Metzger A, Leavitt A, Rahav G, Keller N (2005) Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit. Emerg Infect Dis 11:453–456PubMed Regev-Yochay G, Rubinstein E, Barzilai A, Carmeli Y, Kuint J, Etienne J, Blech M, Smollen G, Maayan-Metzger A, Leavitt A, Rahav G, Keller N (2005) Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit. Emerg Infect Dis 11:453–456PubMed
5.
go back to reference National Committee for Clinical Laboratory Standards (2005) Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. M100-S15. NCCLS, Wayne, Pa National Committee for Clinical Laboratory Standards (2005) Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. M100-S15. NCCLS, Wayne, Pa
6.
go back to reference Schwaber MJ, Navon-Venezia S, Leavitt A, Mekuzas Y, Hammer-Munz O, Schlesinger J, Schwartz D, Carmeli Y (2004) Failure of broth-based tests to detect methicillin-resistant Staphylococcus aureus in a clinical specimen. Eur J Clin Microbiol Infect Dis 23:348–351PubMedCrossRef Schwaber MJ, Navon-Venezia S, Leavitt A, Mekuzas Y, Hammer-Munz O, Schlesinger J, Schwartz D, Carmeli Y (2004) Failure of broth-based tests to detect methicillin-resistant Staphylococcus aureus in a clinical specimen. Eur J Clin Microbiol Infect Dis 23:348–351PubMedCrossRef
7.
go back to reference Oliveira DC, de Lencastre H (2002) Multiplex PCR strategy for rapid identification of structural types anc variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 46:2155–2161PubMedCrossRef Oliveira DC, de Lencastre H (2002) Multiplex PCR strategy for rapid identification of structural types anc variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 46:2155–2161PubMedCrossRef
8.
go back to reference Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG (2000) Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38:1008–1015PubMed Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG (2000) Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38:1008–1015PubMed
9.
go back to reference Jarraud S, Mougel C, Thiolouse J, Lina G, Meugnier H, Forey F et al (2002) Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles) and human disease. Infect Immun 70:631–641PubMedCrossRef Jarraud S, Mougel C, Thiolouse J, Lina G, Meugnier H, Forey F et al (2002) Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles) and human disease. Infect Immun 70:631–641PubMedCrossRef
10.
go back to reference Okuma K, Iwakawa K, Turnidge JD et al (2002) Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 40:4289–4294PubMedCrossRef Okuma K, Iwakawa K, Turnidge JD et al (2002) Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 40:4289–4294PubMedCrossRef
11.
go back to reference Enright MC, Ashley Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 99:7687–7692PubMedCrossRef Enright MC, Ashley Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 99:7687–7692PubMedCrossRef
12.
go back to reference Aires de Sousa M, de Lencastre H (2003) Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA. J Clin Microbiol 42:3806–3815CrossRef Aires de Sousa M, de Lencastre H (2003) Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA. J Clin Microbiol 42:3806–3815CrossRef
13.
go back to reference Charlebois ED, Perdreau-Remington F, Kreiswirth B, Bangsberg DR, Ciccarone D, Diep BA, Ng VL, Chansky K, Edlin B, Chambers HF (2004) Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 39:47–54PubMedCrossRef Charlebois ED, Perdreau-Remington F, Kreiswirth B, Bangsberg DR, Ciccarone D, Diep BA, Ng VL, Chansky K, Edlin B, Chambers HF (2004) Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 39:47–54PubMedCrossRef
14.
go back to reference Holden MT, Feil EF, Lindsay JA et al (2004) Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA 101:9786–9791PubMedCrossRef Holden MT, Feil EF, Lindsay JA et al (2004) Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA 101:9786–9791PubMedCrossRef
15.
go back to reference Wannet WJB, Spalburg E, Heck MEOC, Pluister GN, Willems RJL, de Neeling AJ (2004) Widespread dissemination in the Netherlands of the epidemic Berlin methicillin-resistant Staphylococcus aureus clone with low-level resistance to oxacillin. J Clin Microbiol 42:3077–3082PubMedCrossRef Wannet WJB, Spalburg E, Heck MEOC, Pluister GN, Willems RJL, de Neeling AJ (2004) Widespread dissemination in the Netherlands of the epidemic Berlin methicillin-resistant Staphylococcus aureus clone with low-level resistance to oxacillin. J Clin Microbiol 42:3077–3082PubMedCrossRef
Metadata
Title
Prevalence and genetic relatedness of community-acquired methicillin-resistant Staphylococcus aureus in Israel
Authors
G. Regev-Yochay
Y. Carmeli
M. Raz
E. Pinco
J. Etienne
A. Leavitt
E. Rubinstein
S. Navon-Venezia
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2006
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-006-0210-3

Other articles of this Issue 11/2006

European Journal of Clinical Microbiology & Infectious Diseases 11/2006 Go to the issue

Announcements

Announcements

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.